HCA Healthcare, Inc. financial data

Symbol
HCA on NYSE
Location
Nashville, TN
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99% % -11%
Quick Ratio 11% % -13%
Return On Equity -411% % -170%
Return On Assets 11% % 15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 223,622,200 shares -10%
Common Stock, Shares, Outstanding 224,605,100 shares -10%
Entity Public Float $63,269,000,000 USD 4.8%
Weighted Average Number of Shares Outstanding, Basic 236,413,000 shares -8.6%
Weighted Average Number of Shares Outstanding, Diluted 239,495,000 shares -8.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $75,600,000,000 USD 7.1%
General and Administrative Expense $548,000,000 USD 30%
Costs and Expenses $65,768,000,000 USD 5.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $9,832,000,000 USD 15%
Income Tax Expense (Benefit) $2,050,000,000 USD 9.9%
Net Income (Loss) Attributable to Parent $6,784,000,000 USD 18%
Earnings Per Share, Basic 28.7 USD/shares 29%
Earnings Per Share, Diluted 28.33 USD/shares 29%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,040,000,000 USD -46%
Accounts Receivable, after Allowance for Credit Loss, Current $10,867,000,000 USD 1.1%
Inventory, Net $1,652,000,000 USD -4.9%
Other Assets, Current $2,224,000,000 USD 12%
Assets, Current $15,783,000,000 USD -3.8%
Property, Plant and Equipment, Net $31,141,000,000 USD 5.9%
Operating Lease, Right-of-Use Asset $2,130,000,000 USD -0.05%
Other Assets, Noncurrent $255,000,000 USD 11%
Assets $60,720,000,000 USD 2%
Accounts Payable, Current $4,659,000,000 USD 9%
Liabilities, Current $16,350,000,000 USD 7.7%
Operating Lease, Liability, Noncurrent $1,853,000,000 USD -0.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax $305,000,000 USD 21%
Retained Earnings (Accumulated Deficit) $5,724,000,000 USD -171%
Stockholders' Equity Attributable to Parent $6,027,000,000 USD -141%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2,771,000,000 USD -599%
Liabilities and Equity $60,720,000,000 USD 2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,651,000,000 USD -33%
Net Cash Provided by (Used in) Financing Activities $1,495,000,000 USD -23%
Net Cash Provided by (Used in) Investing Activities $1,032,000,000 USD -14%
Common Stock, Shares Authorized 1,800,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $873,000,000 USD -350%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,040,000,000 USD -46%
Interest Paid, Excluding Capitalized Interest, Operating Activities $539,000,000 USD 0.19%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability $2,205,000,000 USD -0.04%
Payments to Acquire Property, Plant, and Equipment $991,000,000 USD -11%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $6,866,000,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid $3,219,000,000 USD 1.7%
Property, Plant and Equipment, Gross $66,275,000,000 USD 6%
Operating Lease, Liability, Current $352,000,000 USD 2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $413,000,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year One $474,000,000 USD 4.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.053 pure 3.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,014,000,000 USD 5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three $343,000,000 USD -0.29%
Unrecognized Tax Benefits $519,000,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year Four $276,000,000 USD -1.8%
Depreciation, Depletion and Amortization $3,523,000,000 USD 6.4%
Deferred Tax Assets, Net of Valuation Allowance $1,933,000,000 USD 3.2%
Interest Expense $2,248,000,000 USD 9.1%